Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial cell stimulating angiogenesis factor

J B Weiss1, B McLaughlin

  • 1Wolfson Angiogenesis Unit, University of Manchester Rheumatic Disease Centre, Hope Hospital, UK. jweiss@fs1.ho.man.ac.uk

The International Journal of Biochemistry & Cell Biology
|July 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hierarchical Cluster Analysis Using Intraclass Correlations: A Mixture Model Study.

Multivariate behavioral research·2016
Same author

Genetic characterization of healthy and sebaceous adenitis affected Standard Poodles from the United States and the United Kingdom.

Tissue antigens·2012
Same author

Detection of Treponema pallidum, Haemophilus ducreyi, and Herpes Simplex Virus by Multiplex PCR.

Methods in molecular medicine·2011
Same author

Estimated frequency of the canine hyperuricosuria mutation in different dog breeds.

Journal of veterinary internal medicine·2010
Same author

A cluster-randomized trial to improve stroke care in hospitals.

Neurology·2010
Same author

The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

Apoptosis : an international journal on programmed cell death·2004
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Endothelial cell stimulating angiogenesis factor (ESAF) promotes blood vessel growth by activating matrix metalloproteinases. This potent molecule shows therapeutic potential for conditions like ischemic ulcers and fracture repair.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Endothelial cell stimulating angiogenesis factor (ESAF) is a small, non-peptide molecule with significant angiogenic properties.
  • ESAF's mechanism involves activating pro-matrix metalloproteinases and their inhibitors, crucial for angiogenesis.

Purpose of the Study:

  • To investigate the role and therapeutic potential of ESAF in various angiogenic conditions.
  • To understand ESAF's unique mechanism of action on matrix metalloproteinases.

Main Methods:

  • Characterization of ESAF's molecular properties (size, dialyzability).
  • Analysis of ESAF's effect on matrix metalloproteinases and their inhibitors.
  • Correlation of ESAF levels with different physiological and pathological conditions.

Related Experiment Videos

Main Results:

  • ESAF exhibits potent angiogenic activity by modulating matrix metalloproteinases.
  • Elevated ESAF levels are observed in foetal bone growth, stimulated muscle, retinopathy, and brain tumors.
  • ESAF levels are not elevated in rheumatoid arthritis, suggesting specific roles.

Conclusions:

  • ESAF plays a key role in specific angiogenic processes, independent of inflammatory cells.
  • ESAF's unique mechanism and potency suggest therapeutic applications for ischemic conditions and tissue repair.
  • Further research into ESAF analogues could benefit angiogenic diseases like psoriasis and retinopathy.